Orchard Therapeutics plans to go public to raise $172m
Orchard will launch an IPO on the Nasdaq Stock Market to raise $172m to fund research and development.
Archives for October 17, 2018
Sarepta Therapeutics enters manufacturing partnership for DMD treatment
Sarepta Therapeutics signed a long-term, strategic manufacturing partnership with Paragon Bioservices to produce micro-dystrophin to grow its gene therapy program.
MSD adds vaccine and biologics facility next to Keytruda site, creates 170 jobs
MSD will build a second manufacturing plant in County Carlow, Ireland, in response to growing demand.